Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 294

1.

Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users.

Parrott AC, Buchanan T, Scholey AB, Heffernan T, Ling J, Rodgers J.

Hum Psychopharmacol. 2002 Aug;17(6):309-12.

PMID:
12404677
2.

Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study.

Scholey AB, Parrott AC, Buchanan T, Heffernan TM, Ling J, Rodgers J.

Addict Behav. 2004 Jun;29(4):743-52.

PMID:
15135556
3.

Dancing hot on Ecstasy: physical activity and thermal comfort ratings are associated with the memory and other psychobiological problems reported by recreational MDMA users.

Parrott AC, Rodgers J, Buchanan T, Ling J, Heffernan T, Scholey AB.

Hum Psychopharmacol. 2006 Jul;21(5):285-98.

PMID:
16856221
4.

Attributions for psychobiological changes in ecstasy/MDMA and other polydrug users.

Soar K, Parrott A, Turner J.

J Psychopharmacol. 2009 Sep;23(7):745-58. doi: 10.1177/0269881108092594.

PMID:
18635698
5.

Patterns of drug use and the influence of gender on self-reports of memory ability in ecstasy users: a web-based study.

Rodgers J, Buchanan T, Scholey AB, Heffernan TM, Ling J, Parrott AC.

J Psychopharmacol. 2003 Dec;17(4):389-96.

PMID:
14870950
6.

Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users.

Parrott AC, Sisk E, Turner JJ.

Drug Alcohol Depend. 2000 Jul 1;60(1):105-10.

PMID:
10821995
7.

Differential experiences of the psychobiological sequelae of ecstasy use: quantitative and qualitative data from an internet study.

Rodgers J, Buchanan T, Pearson C, Parrott AC, Ling J, Hefferman TM, Scholey AB.

J Psychopharmacol. 2006 May;20(3):437-46.

PMID:
16174668
8.

Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance.

Parrott AC, Lasky J.

Psychopharmacology (Berl). 1998 Oct;139(3):261-8.

PMID:
9784083
9.

Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems.

Parrott AC, Milani RM, Parmar R, Turner JD.

Psychopharmacology (Berl). 2001 Dec;159(1):77-82.

PMID:
11797073
10.

Memory deficits associated with recreational use of "ecstasy" (MDMA).

Morgan MJ.

Psychopharmacology (Berl). 1999 Jan;141(1):30-6.

PMID:
9952062
11.

Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use.

Gouzoulis-Mayfrank E, Fischermann T, Rezk M, Thimm B, Hensen G, Daumann J.

Drug Alcohol Depend. 2005 Jun 1;78(3):317-23.

PMID:
15893163
12.
13.
15.

Recreational ecstasy use and depression.

Guillot C, Greenway D.

J Psychopharmacol. 2006 May;20(3):411-6.

PMID:
16574715
16.

Pattern of cannabis use in ecstasy polydrug users: moderate cannabis use may compensate for self-rated aggression and somatic symptoms.

Milani RM, Parrott AC, Schifano F, Turner JJ.

Hum Psychopharmacol. 2005 Jun;20(4):249-61.

PMID:
15816011
17.

Ecstasy (MDMA) and high prevalence psychiatric symptomatology: somatic anxiety symptoms are associated with polydrug, not ecstasy, use.

Bedi G, Van Dam NT, Redman J.

J Psychopharmacol. 2010 Feb;24(2):233-40. doi: 10.1177/0269881108097631.

PMID:
18832429
18.

Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug.

Fox HC, Parrott AC, Turner JJ.

J Psychopharmacol. 2001 Dec;15(4):273-81.

PMID:
11769821
19.

Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users.

Gouzoulis-Mayfrank E, Thimm B, Rezk M, Hensen G, Daumann J.

Prog Neuropsychopharmacol Biol Psychiatry. 2003 Aug;27(5):819-27.

PMID:
12921915
20.

Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.

de Sola Llopis S, Miguelez-Pan M, Peña-Casanova J, Poudevida S, Farré M, Pacifici R, Böhm P, Abanades S, Verdejo García A, Langohr K, Zuccaro P, de la Torre R.

J Psychopharmacol. 2008 Jul;22(5):498-510. doi: 10.1177/0269881107081545.

PMID:
18208910
Items per page

Supplemental Content

Support Center